Eminence Capital, LP Teva Pharmaceutical Industries LTD Transaction History
Eminence Capital, LP
- $6.62 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding TEVA
# of Institutions
625Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$959 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$809 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$771 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$644 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$592 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $24.8B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...